Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Simple Summary Hepatocellular carcinoma (HCC) is the most common type of liver cancer,
accounting for approximately 85–90% of all cases of liver cancer worldwide. The five-year …

Percutaneous microwave ablation (PMA) is a thermoablative method used as a minimally
invasive treatment for liver cancer. However, the application of PMA is limited by its …

Immune-oncology based regimens have shown efficacy in advanced hepatocellular
carcinoma and have been implemented as standard of care as first line therapy. Their …

Hepatocellular carcinoma (HCC) is a malignancy that requires multidisciplinary evaluation
to develop individualized and tailored treatment concepts. While liver resection and …

Methods Using a retrospective cohort of 506 patients with resected solitary HCCs, the
histological and imaging features of MVI were reviewed and correlated with clinical data …

Simple Summary The treatment of hepatocellular carcinoma is burdened by an
unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no …

Hepatocellular carcinoma (HCC) remains the most common form of liver cancer, accounting
for 90% of all primary liver cancers. Up to 30% of HCC cases could be small (2–3 cm in …

Background Early tumor recurrence is one of the most significant poor prognostic factors for
patients with HCC after R0 resection. The aim of this study is to identify risk factors of early …